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Impact of COVID-19 on 
maternal and child 
health
Timothy Roberton and colleagues1 
estimate the indirect effects of 
COVID-19 on maternal and child 
mortality in low-income and middle-
income countries (LMICs) with 
use of the Lives Saved Tool (LiST), 
suggesting that reduced provision 
and use of reproductive, maternal, 
newborn, and child health-care 
services might substantially increase 
maternal and child deaths. Although 
we commend their efforts, we are 
concerned that omission of stillbirths 
from their analyses has resulted in a 
considerable underestimate of this 
impact.
Each year, more than 2·6 million 
stillbirths occur worldwide, similar 
to the annual burden of 2·5 million 
neonatal deaths and 2·8 million 
post-neonatal deaths of children 
younger than 5 years.2 Stillbirths, 
98% of which occur in LMICs, 
remain a substantial, undercounted 
adverse pregnancy outcome.2 While 
maternal and childhood mortality 
rates have decreased in most regions, 
stillbirth rates remain high, and 
reduction is too slow to meet the 
global target of 12 per 1000 births 
by 2030. Moreover, most stillbirths 
are preventable with access to 
quality health care, particularly when 
including the 1·3 million intrapartum 
stillbirths.2,3
Counting stillbirths is essential 
when assessing adverse maternal 
and child outcomes. The causes of 
maternal and early newborn death 
are almost inseparable from causes 
of stillbirth.3 A woman’s risk of 
having a stillbirth is closely associated 
with her ability to access adequate 
antenatal and obstetric care. The 
most vulnerable pregnant women—
in rural, low-resource, and fragile 
conflict-affected settings—are at 
greatest risk because they already 
have inadequate access to quality care 
that will decrease even further as the 
pandemic continues.2,3
Despite their heavy mortality 
burden and substantial long-term 
psychosocial and financial effects, 
stillbirths remain largely invisible, 
as evidenced by their omission 
from Roberton and colleagues’ 
study.2 The Lancet’s stil lbirth 
Series (2011 and 2016) called on 
governments and other actors to 
integrate stillbirth prevention within 
women’s and children’s health 
initiatives.2–4 In these Series, LiST 
was used to show the triple return 
on investment that such integrated 
action can produce.
In the pre-pandemic world, an 
estimated 823 000 stil lbirths, 
1 145 000 neonatal deaths, and 
166 000 maternal deaths could be 
prevented with universal access to 
antenatal and intrapartum inter-
ventions in 75 high-burden countries.4 
If Roberton and colleagues had 
included stillbirths in their analysis, as 
LiST is designed to do, their findings 
would have reflected the potential 
additional loss of life due to COVID-19 
more accurately.5 Their exclusion of 
stillbirths has missed a substantial 
proportion of deaths that can result 
because of reduced health-care access 
during this pandemic.
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